| Literature DB >> 36060582 |
Xiaomin Li1, Bing Wu1, Yixuan Zou2, Guozhi Zhang2, Siyu Liu1, Lulu Zhao1, Zhengjia Zhang1, Wen Wu3, Chenglei Liu1, Songtao Ai1.
Abstract
Background: Computed tomography (CT) imaging is the most important and common means of detecting and diagnosing pelvic bone tumors. While phantoms with sufficient flexibility and anatomical realism are useful in CT research, using phantoms has been difficult for pelvic bone tumors because of the tumors' relatively large size and highly variable shape. By combining medical 3D printing technology and fresh tumor specimens, this study aimed to design such a hybrid phantom, test its imaging properties, and demonstrate its usefulness in optimizing the CT protocols.Entities:
Keywords: 3D printing; computed tomography; imaging protocol; pelvic bone tumor; pelvic phantom
Year: 2022 PMID: 36060582 PMCID: PMC9403588 DOI: 10.21037/qims-22-147
Source DB: PubMed Journal: Quant Imaging Med Surg ISSN: 2223-4306
Sample patient characteristics
| Characteristics | Patient A | Patient B |
|---|---|---|
| Age (years) | 26 | 58 |
| Gender | Male | Female |
| Pelvic size (diameter × height, cm2) | 37.0×18.5 | 36.0×22.0 |
| Tumor size (width × length × height, cm3) | 8.5×8.2×11.0 | 7.8×12.5×11.5 |
| Diagnosis | Osteochondroma | Chondrosarcoma |
| Enneking’s classification | I | II and III |
| Surgery performed | Excision | Excision and endoprosthetic replacement |
Figure 1The workflow for producing the 3D-printed phantom from CT data. 3D, three-dimension; CT, computed tomography.
Figure 2Assembly of the 3D-printed phantom. (A) The specimen placed into the insert. (B) The phantom assembly. (C) CT scanning of the 3D printed phantom. 3D, three-dimension; CT, computed tomography.
Figure 3Typical images of a pelvic bone tumor. (A) CT images of a patient with a pelvic bone tumor. (B) Bone tumor specimen extracted in surgery. (C) CT image of the phantom with the tumor specimen placed inside. (D) CT image of the specimen placed in the air. The green circle represents the region of interest used for measuring background noise. The red and yellow circles represent the regions of interest used to measure the CT value and noise in bone and soft tissue, respectively. CT, computed tomography.
Figure 4Influence of printing directions and curing times on the tensile property of the 3D-printed material. (A) Three different printing directions for dumbbell-shaped standard splines. (B) The effect of different printing directions and curing time on mechanical properties of 3D-printed dumbbell-shaped standard splines with high-toughness photosensitive resin. 3D, three-dimension.
Figure 5Scanning electron microscopy on 1 section of the 3D-printed dumbbell-shaped standard spline. (A) 100 microns magnification. (B) 20 microns magnification. 3D, three-dimension.
Imaging properties measurements from CT images of the patient with a pelvic bone tumor, the tumor specimen placed in the air, and the proposed phantom
| Imaging properties measurements | Patient image | Specimen image | Phantom image |
|---|---|---|---|
| Background noise | 5.17±3.31 | 1.28±0.55 (P=0.046) | 3.00±1.41 (P=0.071) |
| Bone tissue | |||
| CT value | 1,197.00±17.58 | 1,349.83±20.99 (P<0.001) | 1,216.17±2.48 (P=0.054) |
| SNR | 85.98±56.60 | 123.05±25.10 (P=0.246) | 126.52±19.76 (P=0.170) |
| Soft tissue | |||
| CT value | 73.17±8.35 | 73.00±8.97 (P=0.978) | 71.67±9.18 (P=0.622) |
| SNR | 12.01±6.64 | 18.01±4.28 (P=0.158) | 13.13±6.00 (P=0.815) |
| CNR | 185.82±104.66 | 315.05±57.76 (P=0.088) | 212.97±102.23 (P=0.720) |
CT, computed tomography; SNR, signal to noise ratio; CNR, contrast to noise ratio.
Figure 6Enlarged view of the bone tumor in images of the phantom acquired with different pelvic CT protocols. The white arrows indicate the irregular streak artifacts on soft tissue. The display window width/window level was 300/40 HU for all images. CT, computed tomography.
Measurements in images acquired with different pelvic CT protocols and the associated radiation dose
| CT protocols | kVp | mAs | Pitch | Bone tissue | Soft tissue | Radiation dose | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CT value | Noise | SNR | CT value | Noise | SNR | CNR | CTDIvol (mGy) | DLP (mGy cm) | Effective dose (mSv) | ||||||
| Reference | 140 | 240 | 1 | 1,008.78±38.06 | 20.77±2.85 | 49.38±6.11 | 33.85±4.16 | 12.23±2.79 | 2.91±0.75 | 83.78±18.51 | 29.83 | 881.75 | 13.23 | ||
| Series 1 | 80 | 175 | 1 | 1,410.48±64.34 (P<0.001) | 24.70±8.34 (P=0.348) | 65.77±27.02 (P=0.216) | 36.57±5.05 (P=0.476) | 18.57±2.79 (P=0.011) | 1.97±0.10 (P=0.032) | 75.24±8.56 (P=0.318) | 4.08 | 120.59 | 1.81 | ||
| 100 | 168 | 1 | 1,237.57±42.39 (P<0.001) | 24.22±7.53 (P=0.472) | 64.09±42.52 (P=0.509) | 35.28±2.61 (P=0.589) | 18.40±2.30 (P=0.010) | 1.95±0.26 (P=0.042) | 66.31±8.02 (P=0.105) | 8.32 | 246.14 | 3.69 | |||
| 120 | 149 | 1 | 1,080.32±42.22 (P<0.001) | 19.63±4.47 (P=0.547) | 58.76±16.78 (P=0.202) | 32.27±3.09 (P=0.475) | 15.77±2.94 (P=0.078) | 2.14±0.55 (P=0.099) | 69.44±16.50 (P=0.164) | 12.44 | 368.09 | 5.52 | |||
| 140 | 134 | 1 | 1,009.43±35.12 (P=0.871) | 20.07±5.58 (P=0.714) | 54.75±16.23 (P=0.369) | 31.37±1.86 (P=0.102) | 12.93±4.21 (P=0.786) | 2.74±1.00 (P=0.759) | 84.19±26.76 (P=0.982) | 16.59 | 490.88 | 7.36 | |||
| Series 2 | 140 | 80 | 1 | 1,016.03±36.08 (P=0.472) | 19.13±9.76 (P=0.748) | 67.40±29.44 (P=0.248) | 33.05±4.44 (P=0.811) | 13.53±5.37 (P=0.728) | 3.11±1.95 (P=0.871) | 86.61±38.57 (P=0.914) | 9.94 | 294.14 | 4.41 | ||
| 140 | 120 | 1 | 1,016.12±46.76 (P=0.306) | 19.95±7.68 (P=0.805) | 62.48±32.91 (P=0.397) | 31.47±4.17 (P=0.347) | 13.37±1.54 (P=0.347) | 2.41±0.57 (P=0.056) | 74.55±8.07 (P=0.275) | 14.92 | 441.5 | 6.62 | |||
| 140 | 160 | 1 | 1,000.63±38.30 (P=0.249) | 20.92±8.35 (P=0.963) | 64.33±43.89 (P=0.443) | 31.53±1.08 (P=0.273) | 12.83±3.23 (P=0.629) | 2.59±0.54 (P=0.276) | 79.61±17.30 (P=0.400) | 19.89 | 588.57 | 8.83 | |||
| 140 | 200 | 1 | 998.60±43.31 (P=0.162) | 20.55±3.95 (P=0.864) | 50.8±12.29 (P=0.755) | 31.48±6.76 (P=0.593) | 11.57±2.98 (P=0.417) | 2.93±0.98 (P=0.953) | 88.79±20.24 (P=0.524) | 24.83 | 734.75 | 11.02 | |||
| Series 3 | 140 | 212 | 0.5 | 1,012.40±38.98 (P=0.619) | 18.78±8.86 (P=0.641) | 71.28±38.77 (P=0.24) | 30.68±3.00 (P=0.316) | 9.70±2.56 (P=0.222) | 3.36±0.74 (P=0.309) | 109.54±32.23 (P=0.209) | 26.37 | 772.84 | 11.59 | ||
| 140 | 176 | 0.8 | 1,013.23±46.41 (P=0.620) | 20.00±4.59 (P=0.770) | 53.46±12.90 (P=0.540) | 30.58±6.07 (P=0.485) | 12.95±6.22 (P=0.807) | 2.91±1.14 (P=0.990) | 105.76±64.30 (P=0.502) | 21.91 | 644.92 | 9.67 | |||
| 140 | 117 | 1.1 | 1,018.32±39.03 (P=0.399) | 20.87±9.72 (P=0.979) | 57.83±20.57 (P=0.303) | 30.27±5.62 (P=0.375) | 13.53±3.41 (P=0.581) | 2.36±0.68 (P=0.302) | 77.84±19.86 (P=0.683) | 14.59 | 432.85 | 6.49 | |||
| 140 | 92 | 1.4 | 1,000.03±32.79 (P=0.403) | 21.37±1.86 (P=0.683) | 47.23±5.06 (P=0.524) | 30.08±4.90 (P=0.066) | 20.2±4.61 (P=0.018) | 1.57±0.42 (P=0.007) | 51.68±17.12 (P=0.014) | 11.46 | 341.58 | 5.12 | |||
CT, computed tomography; SNR, signal to noise ratio; CNR, contrast to noise ratio; CTDIvol, volume CT dose index; DLP, dose-length product.